通过抑制Timp1-Wnt2b轴,MSC减弱了HDM诱导的喘中的气道重塑
Kai Yu1, Xinyu Feng2, Rong Zhang3
1Department of General Practice, Changhai Hospital, Naval Military Medical University, Shanghai 200433, China.
Acta biochimica et biophysica Sinica
|September 26, 2025
概括
介酶干细胞 (MSCs) 通过减少呼吸道重塑来治疗喘. 在小鼠模型中,它们抑制Timp1-Wnt2b轴,逆转纤维化并改善呼吸功能.
科学领域:
- 再生医学是一种再生医学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 介质细胞干细胞 (MSCs) 显示出对呼吸系统疾病的治疗前景.
- 对于喘治疗的MSC应用仍未得到充分探索.
- 喘涉及慢性呼吸道炎症和重塑.
研究的目的:
- 为了研究MSCs在治疗慢性喘模型中的有效性.
- 阐明MSCs反气道改造效应背后的分子机制.
- 确定参与MSC介导喘治疗的关键途径和基因.
主要方法:
- 在小鼠中使用室内灰尘虫 (HDM) 诱导建立了一种慢性喘模型.
- 介质干细胞 (MSCs) 通过尾静脉注射进行了注射.
- RNA测序 (RNA-seq) 分析了转录基因变化,随后进行了西方斑点验证.
- STRING分析探索了基因相互作用,而体外/体内实验测试了Timp1过度表达效应.
主要成果:
- MSC治疗逆转了HDM诱导的气道改造和抑制了喘.
- HIF-1信号通路被抑制,Timp1和Wnt2b的表达减少.
- 气道改造的MSC介导逆转取决于Timp1抑制.
- 在MSC中Timp1的过度表达取消了它们的治疗效果.
结论:
- 在慢性喘模型中,MSCs有效地减轻了呼吸道改造.
- 治疗机制涉及Timp1-Wnt2b轴的抑制.
- 向Timp1-Wnt2b通路为喘提供了一个潜在的治疗策略.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K


